Selected research
Industry Research
Mood Stabilizers Industry Research Report 2026
Market perspective
The global Mood Stabilizers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Mood Stabilizers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Mood Stabilizers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Mood Stabilizers include Pfizer, GlaxoSmithKline, Otsuka Pharmaceutical and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Mood Stabilizers market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mood Stabilizers Market by Company
Pfizer
GlaxoSmithKline
Otsuka Pharmaceutical
Bristol-Myers Squibb
Mood Stabilizers Segment by Type
Asenapine
Valproate
Carbamazepine
Lamotrigine
Mood Stabilizers Segment by Application
Hospital Pharmacies
Drug Stores
Others
Mood Stabilizers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mood Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mood Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mood Stabilizers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mood Stabilizers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mood Stabilizers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mood Stabilizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Asenapine
- Valproate
- Carbamazepine
- Lamotrigine
Applications
- Hospital Pharmacies
- Drug Stores
- Others
Companies covered
- Pfizer
- GlaxoSmithKline
- Otsuka Pharmaceutical
- Bristol-Myers Squibb
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mood Stabilizers Market Size (2021-2032)
- 2.2.2 Global Mood Stabilizers Sales (2021-2032)
- 2.2.3 Global Mood Stabilizers Market Average Price (2021-2032)
- 2.3 Mood Stabilizers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Asenapine
- 2.3.3 Valproate
- 2.3.4 Carbamazepine
- 2.3.5 Lamotrigine
- 2.4 Mood Stabilizers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Drug Stores
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mood Stabilizers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mood Stabilizers Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Mood Stabilizers Revenue of Manufacturers (2021-2026)
- 3.4 Global Mood Stabilizers Average Price by Manufacturers (2021-2026)
- 3.5 Global Mood Stabilizers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mood Stabilizers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mood Stabilizers, Product Type & Application
- 3.8 Global Manufacturers of Mood Stabilizers, Established Date
- 3.9 Global Mood Stabilizers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Mood Stabilizers Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 GlaxoSmithKline
- 4.2.1 GlaxoSmithKline Company Information
- 4.2.2 GlaxoSmithKline Business Overview
- 4.2.3 GlaxoSmithKline Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GlaxoSmithKline Mood Stabilizers Product Portfolio
- 4.2.5 GlaxoSmithKline Recent Developments
- 4.3 Otsuka Pharmaceutical
- 4.3.1 Otsuka Pharmaceutical Company Information
- 4.3.2 Otsuka Pharmaceutical Business Overview
- 4.3.3 Otsuka Pharmaceutical Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Otsuka Pharmaceutical Mood Stabilizers Product Portfolio
- 4.3.5 Otsuka Pharmaceutical Recent Developments
- 4.4 Bristol-Myers Squibb
- 4.4.1 Bristol-Myers Squibb Company Information
- 4.4.2 Bristol-Myers Squibb Business Overview
- 4.4.3 Bristol-Myers Squibb Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bristol-Myers Squibb Mood Stabilizers Product Portfolio
- 4.4.5 Bristol-Myers Squibb Recent Developments
5 Global Mood Stabilizers Market Scenario by Region
- 5.1 Global Mood Stabilizers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mood Stabilizers Sales by Region: 2021-2032
- 5.2.1 Global Mood Stabilizers Sales by Region: 2021-2026
- 5.2.2 Global Mood Stabilizers Sales by Region: 2027-2032
- 5.3 Global Mood Stabilizers Revenue by Region: 2021-2032
- 5.3.1 Global Mood Stabilizers Revenue by Region: 2021-2026
- 5.3.2 Global Mood Stabilizers Revenue by Region: 2027-2032
- 5.4 North America Mood Stabilizers Market Facts & Figures by Country
- 5.4.1 North America Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mood Stabilizers Sales by Country (2021-2032)
- 5.4.3 North America Mood Stabilizers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Mood Stabilizers Market Facts & Figures by Country
- 5.5.1 Europe Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mood Stabilizers Sales by Country (2021-2032)
- 5.5.3 Europe Mood Stabilizers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Mood Stabilizers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mood Stabilizers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mood Stabilizers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mood Stabilizers Market Facts & Figures by Country
- 5.7.1 South America Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mood Stabilizers Sales by Country (2021-2032)
- 5.7.3 South America Mood Stabilizers Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Mood Stabilizers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mood Stabilizers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mood Stabilizers Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Mood Stabilizers Sales by Type (2021-2032)
- 6.1.1 Global Mood Stabilizers Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Mood Stabilizers Sales Market Share by Type (2021-2032)
- 6.2 Global Mood Stabilizers Revenue by Type (2021-2032)
- 6.2.1 Global Mood Stabilizers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mood Stabilizers Revenue Market Share by Type (2021-2032)
- 6.3 Global Mood Stabilizers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mood Stabilizers Sales by Application (2021-2032)
- 7.1.1 Global Mood Stabilizers Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Mood Stabilizers Sales Market Share by Application (2021-2032)
- 7.2 Global Mood Stabilizers Revenue by Application (2021-2032)
- 7.2.1 Global Mood Stabilizers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mood Stabilizers Revenue Market Share by Application (2021-2032)
- 7.3 Global Mood Stabilizers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mood Stabilizers Value Chain Analysis
- 8.1.1 Mood Stabilizers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mood Stabilizers Production Mode & Process
- 8.2 Mood Stabilizers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mood Stabilizers Distributors
- 8.2.3 Mood Stabilizers Customers
9 Global Mood Stabilizers Analyzing Market Dynamics
- 9.1 Mood Stabilizers Industry Trends
- 9.2 Mood Stabilizers Industry Drivers
- 9.3 Mood Stabilizers Industry Opportunities and Challenges
- 9.4 Mood Stabilizers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst